Seeing Is Believing
Currently out of the existing stock ratings of Joseph Catanzaro, 216 are a BUY (76.6%), 66 are a HOLD (23.4%).
Analyst Joseph Catanzaro works at PIPER SANDLER with a stock forecast success ratio of 36.85% fulfilled within 131.94 days on average.
Joseph Catanzaro’s has documented 543 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on IBRX, Immunitybio at 29-Apr-2024.
Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for CPRX (CATALYST PHARMACEUTICALS) at 11/10/2021. The price target of $7 was fulfilled within 1 day with a profit of $0.55 (8.53%) receiving and performance score of 85.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5
$3 (150.00%)
30
4 months 22 days ago
0/5 (0%)
$2.66 (113.68%)
Hold
4 months 22 days ago
0/4 (0%)
$31.56 (191.97%)
Buy
4 months 22 days ago
0/1 (0%)
$20.97 (87.27%)
Buy
2 years 26 days ago
0/1 (0%)
$93 (163.16%)
Buy
2 years 26 days ago
2/2 (100%)
$4.5 (25.00%)
82
Which stock is Joseph Catanzaro is most bullish on?
Which stock is Joseph Catanzaro is most reserved on?
What Year was the first public recommendation made by Joseph Catanzaro?